Page 21 - Pfizer

Decoded: What emergency use authorisation of Covid vaccine means for us

After the Indian arm of US pharmaceutical giant Pfizer, the Serum Institute of India has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation

India weighing quick emergency review of Pfizer, AstraZeneca vaccines

Serum Institute is making AstraZeneca's Covid-19 vaccine in India and has applied for emergency use authorisation.

Pfizer working on cold storage issues to ensure temperature integrity

The company has developed detailed logistical plans and tools to support effective vaccine transport, storage, and temperature monitoring.

UK ready for roll-out; Pfizer CEO not certain if shot stops spread

US, China also set to start process of inoculating their citizens from this week

Pfizer, BioNtech in final stages of talks with WHO to join Covax alliance

The ultra-cold chain requirement of Pfizer's vaccine, unlike most other vaccines, makes it a challenge for most countries including India to store and transport

Vaccine supply chains bend but don't break as firms rise to challenges

Supply chains have been tested in ways they never have been before and, yes, there have been pileups, shortages and other snafus

Fauci apologizes for casting doubt over UK's approval of Pfizer vaccine

"I do have great faith in both the scientific community and the regulatory community in the UK," Fauci said

Fortune or foresight? AstraZeneca, Oxford stories clash on Covid-19 vaccine

The discrepancy, reported for the first time by Reuters, centres on the regimen administered to a smaller group of volunteers in the late-stage trials, of half a dose followed by a full dose

Covid updates: AIIMS chief on vaccine, former US presidents' awareness move

Facebook released a statement on Thursday, saying in coming weeks the company will start removing false claims about vaccines that have been debunked by public health experts

Supply chain challenges led to target cut for Covid vaccine doses: Pfizer

Challenges in Pfizer's supply chain for the raw materials used in its Covid-19 vaccine played a role in its decision to slash its 2020 production target, a Pfizer spokeswoman said

High-stakes coronavirus vaccine rollout under spotlight amid challenges

The UK has ordered enough doses of the two-shot Pfizer-BioNTech vaccine to immunise 20 million people

Committed to engaging with Indian govt to bring Covid-19 vaccine: Pfizer

The UK on Wednesday became the first country to approve the Pfizer/BioNTech vaccine.

World Coronavirus Dispatch: How UK leaped ahead of US, EU to allow vaccine

Japan gears up for large Olympic crowds, Covid crisis fuels global wage inequality, IMF chief warns against complacency on global economy, and other pandemic-related news across the globe

India Coronavirus Dispatch: Vaccine volunteers say the risk was worth it

Is the Pfizer vaccine the right fit for India, celebrity ambassadors to drum up interest in vaccinations, how herd immunity works-news relevant to India's fight against Covid-19

There will be more Covid vaccine doses than needed by 2021 end: Pfizer CEO

Pfizer's chief executive Albert Bourla said he was confident that by the end of 2021 there would be more vaccine doses than required to fight the Covid-19 pandemic

Don't get carried away with Covid-19 vaccine 'over optimism': UK PM Johnson

UK PM Johnson hailed the "searchlights of science" which have fought back against Covid-19 with an approved Pfizer/BioNTech vaccine but urged the public to not get carried away with "over optimism"

UK approves Pfizer, becomes the first country to roll out Covid-19 vaccine

With 800,000 doses expected to be delivered over the next few days, inoculations will begin next week

Vaccine on horizon, plans are afoot for real-time supply chain tracking

Experts feel it would be critical to spot spurious vaccines, enable faster product recalls and ensure two shots to individual from same manufacturer

Covid vaccination debut

The UK's experience could provide some pointers

Top headlines: Ant considers Paytm stake sale, UK nod to Pfizer vaccine

US court rejects Trump rules limiting H1-B visas to skilled workers, Maruti Suzuki sees 'much better' 2021, govt gets three bids for BPCL, and more top headlines of the day